Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. Mai 2014 12:00 ET | Quelle: Genelux

Genelux Appoints George Vandeman and Thomas Zindrick to Board of Directors

SAN DIEGO, CA--(Marketwired - May 28, 2014) - Genelux Corporation, a clinical-stage biopharmaceutical company that develops vaccinia virus-based cancer therapeutics and diagnostics, today announced...
15. Mai 2014 13:17 ET | Quelle: Genelux

Update: Genelux Corporation Announces Former Amgen and Abbott Executives to Succeed Founder Aladar A. Szalay, Ph.D., as CEO, Chairman of the Board

SAN DIEGO, CA--(Marketwired - May 15, 2014) - Genelux Corporation, a clinical-stage biopharmaceutical company that develops vaccinia virus-based cancer therapeutics and diagnostics, today...
12. Mai 2014 10:58 ET | Quelle: Genelux

Genelux Corporation Announces Former Amgen and Abbott Executives to Succeed Founder Aladar A. Szalay, Ph.D., as CEO, Chairman of the Board

SAN DIEGO, CA--(Marketwired - May 12, 2014) - Genelux Corporation, a clinical-stage biopharmaceutical company that develops vaccinia virus-based cancer therapeutics and diagnostics, today announced...
08. April 2014 11:17 ET | Quelle: Genelux

Genelux Corporation CEO, Dr. Aladar A. Szalay, to Give a Keynote Lecture at the 8th International Conference on Oncolytic Virus Therapeutics

SAN DIEGO, CA--(Marketwired - Apr 8, 2014) - Genelux Corporation, a clinical-stage biopharmaceutical company developing vaccinia virus-based cancer therapies and diagnostics, today announced that...
11. Februar 2014 08:00 ET | Quelle: Genelux

Genelux Corporation Appoints John D. Prunty Chief Financial Officer

SAN DIEGO, CA--(Marketwired - Feb 11, 2014) - Genelux Corporation, a clinical-stage biopharmaceutical company that develops vaccinia virus-based cancer therapeutics and diagnostics, announced today...